| Followers | 9887 |
| Posts | 261364 |
| Boards Moderated | 4 |
| Alias Born | 12/27/2006 |
Monday, May 18, 2020 9:20:42 AM
Thanks for the feedback.
Recent AMRX News
- Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/27/2026 08:20:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/25/2026 08:16:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/25/2026 08:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:52:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:51:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:25 PM
- Amneal to Participate in Upcoming Investor Conference • GlobeNewswire Inc. • 03/05/2026 09:05:00 PM
- Amneal Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/27/2026 11:00:00 AM
- Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market • PR Newswire (US) • 02/13/2026 04:26:00 PM
- Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market • PR Newswire (Canada) • 02/13/2026 04:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 09:16:01 PM
- Amneal Pharmaceuticals Added to S&P SmallCap 600® Index • GlobeNewswire Inc. • 01/28/2026 09:05:00 PM
- TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 • PR Newswire (US) • 01/27/2026 11:02:00 PM
- Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 • GlobeNewswire Inc. • 01/27/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2026 12:44:49 PM
- Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA® • GlobeNewswire Inc. • 12/22/2025 09:01:00 PM
- mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA® • PR Newswire (US) • 12/22/2025 09:00:00 PM
- Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals • GlobeNewswire Inc. • 12/09/2025 09:01:00 PM
- Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease • GlobeNewswire Inc. • 12/05/2025 01:00:00 PM
- Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol • GlobeNewswire Inc. • 12/02/2025 01:00:00 PM
- Amneal to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 12/02/2025 01:00:00 PM
- Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05% • GlobeNewswire Inc. • 12/01/2025 09:01:00 PM
